We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




A Subset of Immune T-Cells Protects Against Metabolic Syndrome in Mouse Model

By LabMedica International staff writers
Posted on 16 Nov 2015
A subset of immune T-cells lacking the lytic protein perforin was found to be responsible for inducing the onset of metabolic syndrome (obesity, high blood pressure, high levels of blood sugar and cholesterol) in mice fed a normal diet.

Investigators at the Weizmann Institute of Science (Rehovot, Israel) were seeking molecular clues that would clarify the emerging evidence that immunological mechanisms underlie metabolic control of adipose tissue.

To this end they used bone marrow transplantation to generate a line of mice that lacked the perforin-containing granules (perf-DCs) normally found in this subset of dendritic T-cells. More...
Perforin is a protein that creates transmembrane tubules and is capable of lysing non-specifically a variety of target cells. This protein is one of the main cytolytic proteins of cytolytic granules, and it is known to be a key effector molecule for T-cell- and natural killer-cell-mediated cytolysis.

The investigators reported in the September 15, 2015, online edition of the journal Immunity that the perforin-deficient mice progressively gained weight and exhibited features of metabolic syndrome. This phenotype was associated with an altered repertoire of T-cells residing in adipose tissue and could be completely prevented by T-cell depletion in vivo.

A similar impact of perf-DCs on inflammatory T-cells was also found in a well-defined model of multiple sclerosis, experimental autoimmune encephlalomyelitis (EAE). Thus, perf-DCs probably represent a regulatory cell subpopulation critical for protection from metabolic syndrome and autoimmunity.

Related Links:

Weizmann Institute of Science



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.